Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China flag China · Delayed Price · Currency is CNY
12.17
+0.16 (1.33%)
Mar 10, 2026, 3:00 PM CST

Hunan Fangsheng Pharmaceutical Company Description

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.

The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs.

The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue capsules, Lysine Vitamin B12 granules, Cefuroxime tablets, Jinying capsules, Pudilan anti-inflammatory tablets, Xiaoer Jingxing cough granules, Ezetimibe tablets, Xuanqi bone-strengthening tablets, Qiangli Loquat Paste (honey-refined), and Qiangli Loquat Dew and others.

It also offers other businesses, such as medical services, pharmaceutical commerce, and drug sales. The company was founded in 2002 and is based in Changsha, China.

Hunan Fangsheng Pharmaceutical Co., Ltd.
Country China
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,807
CEO Xiaoli Zhou

Contact Details

Address:
No. 299, Jiayun Road
Changsha, Hunan Province 410205
China
Website fangsheng.com.cn

Stock Details

Ticker Symbol 603998
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001VG6
SIC Code 2834

Key Executives

Name Position
Xiaoli Zhou GM and Chairman
Chen Bo Deputy GM and Director
Shi He Board Secretary
Xiangqi Cao Financial Director and Accounting Supervisor